Thermo Fisher Scientific | TMO - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
Abbott USD 2.39B 27M 2026-03
Agilent USD 364M 78M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bio Techne USD 50.78M 34.21M 2025-12
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
Boston Scientific USD 700M 238M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Danaher USD 1.08B 157M 2026-06
Dentsply International USD -42M 105M 2026-03
Edwards Lifesciences USD 348.4M 51.8M 2025-09
General Electric Aerospace USD 2.2B 654M 2026-03
Henry Schein USD 150M 17M 2026-03
Illumina USD 157M 220M 2026-03
Intuitive Surgical USD 940.4M 15.2M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
Laboratory Of America USD 8.73B 8.54B 2026-03
Medtronic USD 2.45B 1.04B 2026-03
Mettler Toledo International USD 329.07M 59.84M 2025-12
Myriad Genetics USD 4.6M 3.4M 2025-12
Olympus JPY 27.08B 4.95B 2026-03
OraSure Technologies USD -18.43M 5.14M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Repligen USD 19.11M 2M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Stryker USD 1.7B 676M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veracyte USD 29.97M 10.66M 2026-03
Waters USD 264.18M 94.06M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12